Table 2. Baseline Characteristics, all patients (n=60).
Age at study entry | median in years (IQR) | 62.6 (52.7, 69.3) |
---|---|---|
Disease status | refractory | 10 (17%) |
first relapse | 47 (78%) | |
2 or more relapses | 3 (5%) | |
Prior HiDAC | Yes | 21 (35%) |
no | 39 (65%) | |
Duration of CR1 | median in months (IQR) | 9.0 (4.0, 13.0) |
FAB Classifications | n/a | 3 (5%) |
AML | 3 (5%) | |
M0 | 5 (8%) | |
M1 | 10 (16%) | |
M2 | 15 (25%) | |
M4 | 14 (23%) | |
M5B | 1 (2%) | |
M6 | 3 (5%) | |
M7 | 1 (2%) | |
MDS (RAEB) | 2 (3%) | |
Multilineage | 2 (3%) | |
t-AML | 1 (2%) |